Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Therapy Oncolytics|March 23, 2022
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trialsShuhang Wang, Yuqi Yang, Peiwen Ma, et al.
Frontiers in Immunology|September 30, 2022
Association between germ-line HLA and immune-related adverse eventsNing Jiang, Yue Yu, Min Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2024
Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A reviewPeiwen Ma, Yale Jiang, Guo Zhao, et al.
The Lancet. Oncology|November 3, 2022
Accelerating the integration of China into the global development of innovative anticancer drugsHuiyao Huang, Dawei Wu, Huilei Miao, et al.
Cancer Letters|June 2, 2024
Exosome-based anticancer vaccines: From Bench to bedsideGuo Zhao, Yuning Wang, Shujun Xing, et al.
Orphanet Journal of Rare Diseases|September 5, 2020
Bone mineral density and bone microarchitecture in a cohort of patients with Erdheim-Chester DiseaseTianhua He, Lijia Cui, Na Niu, et al.
Vaccines|July 27, 2022
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine DevelopmentShuhang Wang, Yuqi Yang, Lu Li, et al.
Frontiers of Medicine|May 15, 2023
Rare tumors: a blue ocean of investigationShuhang Wang, Peiwen Ma, Ning Jiang, et al.
EMBO Molecular Medicine|November 28, 2022
Targeting rare tumors: new focus for clinical research in ChinaShuhang Wang, Yale Jiang, Huilei Miao, et al.
EMBO Molecular Medicine|August 25, 2021
The state of the art of bispecific antibodies for treating human malignanciesShuhang Wang, Kun Chen, Qi Lei, et al.
Pageof 3